🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Achievement of complete hematologic response (CHR) is vital for systemic AL...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2024-01-05
Trial ID
NCT06192979
Treatments Being Tested
The purpose of this study is to investigate whether teclistamab-daratumumab...
Status
Recruiting
Location
Boston Medical Center
Start Date
2025-11-07
Trial ID
NCT07110844
Treatments Being Tested
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
This is a prospective and single arm clinical study. The goal of this clini...
Status
Unknown
Location
The First Affiliated Hospital of Wenzhou Medical University
Start Date
2024-03-01
Trial ID
NCT06455748
Treatments Being Tested
TAK-981 is being tested in combination with anti-CD38 monoclonal antibodies...
Status
Terminated
Location
Mayo Clinic Arizona - PPDS
Start Date
2021-04-20
Trial ID
NCT04776018
Treatments Being Tested
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
This study will test the safety of TTI-622 in combination with daratumumab ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2021-10-28
Trial ID
NCT05139225
Treatments Being Tested
This phase III trial compares the combination of four drugs (daratumumab, b...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-02-24
Trial ID
NCT04566328
The purpose of this study is to determine the overall response rate of pati...
Status
Terminated
Location
UCSD Moores Cancer Center
Start Date
2018-10-17
Trial ID
NCT03590652
This phase I trial studies the side effects and best dose of selvigaltin wh...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2026-04-01
Trial ID
NCT07082270
Treatments Being Tested